Twitter Inc (TWTR) Option Bulls Root for an End-of-Year Rally

Calls continue to be the options of choice on struggling Twitter Inc

by Karee Venema

Published on Dec 16, 2014 at 12:49 PM
Updated on Apr 20, 2015 at 5:32 PM

Twitter Inc (NYSE:TWTR) is down 1.6%, following a price-target cut to $45 from $55 at Evercore ISI -- although the brokerage firm maintained its "buy" rating. Nevertheless, calls are outpacing puts by a nearly 2-to-1 margin. Meanwhile, the stock's 30-day at-the-money implied volatility is up 1.5% at 49.7%, signaling elevated demand for short-term options.

Seeing the most action in TWTR's options pits today are the December 36 and weekly 12/26 41.50-strike calls. It appears the majority of the 12,887 contracts traded across these two strikes have been bought to open, as traders roll the dice on a quick bounce over the next two weeks.

From a wider sentiment perspective, today's call-skewed session just echoes the withstanding trend. Specifically, the equity's 50-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 2.44 ranks in the 88th annual percentile. Additionally, TWTR's Schaeffer's put/call open interest ratio (SOIR) of 0.60 rests below 75% of similar readings taken in the past year.

Technically speaking, however, Twitter Inc (NYSE:TWTR) has been on a steady downtrend since hitting its most recent high of $55.99 in early October, with the shares off 35.2% to trade at $36.27. Should the shares continue to struggle, a capitulation from option bulls could translate into a fresh wave of selling pressure.


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.